Item Type | Name |
Academic Article
|
Clofarabine ? fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS.
|
Concept
|
Serum Albumin, Bovine
|
Concept
|
Antilymphocyte Serum
|
Concept
|
Serum Albumin
|
Academic Article
|
Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT.
|
Academic Article
|
Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome.
|
Academic Article
|
Unrelated donor transplantation for acute myelogenous leukemia in first remission.
|
Academic Article
|
Serum cholesterol-lowering activity of granulocyte-macrophage colony-stimulating factor.
|
Academic Article
|
Matched unrelated donor bone marrow transplantation for the treatment of platinum refractory ovarian carcinoma: a case report.
|
Academic Article
|
Anaphylaxis to infusion of autologous bone marrow: an apparent reaction to self, mediated by IgE antibody to bovine serum albumin.
|
Academic Article
|
Pure red cell aplasia characterized by erythropoietic maturation arrest. Response to anti-thymocyte globulin.
|
Academic Article
|
Do androgens enhance the response to antithymocyte globulin in patients with aplastic anemia? A prospective randomized trial.
|
Academic Article
|
Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplant.
|
Academic Article
|
Transient response of pure red cell aplasia to anti-thymocyte globulin in a patient with T-cell chronic lymphocytic leukemia.
|
Academic Article
|
Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia.
|
Academic Article
|
Treatment of aplastic anemia: results with bone marrow transplantation, antithymocyte globulin, and a monoclonal anti-T cell antibody.
|
Academic Article
|
Comparison between bone marrow transplantation and antithymocyte globulin in treatment of young patients with severe aplastic anemia.
|
Academic Article
|
Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation.
|
Academic Article
|
Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease.
|
Academic Article
|
Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation.
|
Academic Article
|
Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.
|
Academic Article
|
Fludarabine, cyclophosphamide, and antithymocyte globulin for matched related and unrelated allogeneic stem cell transplant in severe aplastic anemia.
|
Academic Article
|
High incidence of vitamin D deficiency in patients undergoing allogeneic stem cell transplantation.
|
Academic Article
|
Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission.
|
Academic Article
|
In vitro production of granulocyte-macrophage colony-stimulating factor in aplastic anemia: possible mechanisms of action of antithymocyte globulin.
|
Academic Article
|
Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial.
|
Academic Article
|
Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens.
|
Academic Article
|
Fludarabine, melphalan, thiotepa and anti-thymocyte globulin conditioning for unrelated cord blood transplant.
|
Academic Article
|
Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies.
|
Academic Article
|
Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemia.
|
Academic Article
|
Clinical outcomes in adult patients with aplastic anemia: A single institution experience.
|
Academic Article
|
Azithromycin may increase hematologic relapse rates in matched unrelated donor hematopoietic cell transplant recipients who receive anti-thymocyte globulin, but not in most other recipients.
|
Academic Article
|
Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis.
|